Genomics

Dataset Information

TMB in NSCLC patients treated with combination immunotherapy


ABSTRACT: Tumor mutation burden estimated with whole exome sequencing of 43 NSCLC patient tumors treated with anti-PD-1 + anti-CTLA-4

INSTRUMENT(S): -

ORGANISM(S): Homo Sapiens

SUBMITTER: MSKCC 

PROVIDER: PRJEB24995 | EVA | 2018-02-15

REPOSITORIES: EVA